AVENUE THERAPEUTICS, INC.
Total Trades
6
Buys
3
Sells
3
Largest Trade
$1M+
Insiders
5
Institutional Funds
1
Inst. Value
$15K–$50K
Activist Filings
14
Insider Trades
| Insider | Title | Type | Value | Shares | Price | Date |
|---|---|---|---|---|---|---|
| Herskowitz Neil | Director | SELL | <$1K | 23 | $2.00 | Dec 3, 2024 |
| KRANZLER JAY D | Director | SELL | <$1K | 61 | $2.24 | Nov 8, 2024 |
| KRANZLER JAY D | Director | BUY | $1K–$15K | 500 | $2.50 | Oct 1, 2024 |
| ROSENWALD LINDSAY A MD | Director | BUY | $100K–$500K | 349K | $0.72 | Sep 12, 2023 |
| Fortress Biotech, Inc. | 10% Owner | BUY | $100K–$500K | 418K | $0.72 | Sep 12, 2023 |
| InvaGen Pharmaceuticals, Inc. | 10% Owner | SELL | $1M+ | 389K | $7.71 | Oct 14, 2022 |
Institutional Ownership
13F filings as of Sep 30, 2023 · 1 funds holding
| Fund | Shares | Value | Type |
|---|---|---|---|
| VANGUARD GROUP INC | 46K | $15K–$50K | SH |
Activist & 5%+ Owners
SC 13D/13G filings — investors holding 5%+ of outstanding shares
Fortress Biotech, Inc. 20-5157386
SC 13D/A · Apr 17, 2024
8.0%
3.6M shares
Sabby Volatility Warrant Master Fund, Ltd.
SC 13G/A · Jan 2, 2024
5.0%
661K shares
SC 13G/A · Dec 13, 2023
9.9%
1.3M shares
SC 13G · Nov 28, 2023
14.5%
1.9M shares
Fortress Biotech, Inc. 20-5157386
SC 13D/A · Sep 18, 2023
12.1%
1.0M shares
SC 13G/A · Feb 14, 2023
4.9%
251K shares
Fortress Biotech, Inc. 20-5157386
SC 13D/A · Jan 6, 2023
11.3%
578K shares
Sabby Volatility Warrant Master Fund, Ltd.
SC 13G · Jan 4, 2023
5.5%
264K shares
Nantahala Capital Management, LLC
SC 13G/A · Dec 14, 2022
0.0%
0 shares
INVAGEN PHARMACEUTICALS INC. 20-1420845
SC 13D/A · Oct 19, 2022
0.0%
0 shares
SC 13G · Oct 17, 2022
6.6%
273K shares
SC 13G · Oct 17, 2022
45.0%
4.2M shares
INVAGEN PHARMACEUTICALS INC. 20-1420845
SC 13D/A · Jul 28, 2022
47.0%
10.7M shares
Nantahala Capital Management, LLC
SC 13G · Feb 14, 2022
7.7%
1.5M shares